NxStage Medical Inc (NASDAQ:NXTM)

16.66
Delayed Data
As of Mar 03
 -0.43 / -2.52%
Today’s Change
10.69
Today|||52-Week Range
19.19
-7.08%
Year-to-Date

Today’s Trading

Previous close17.09
Today’s open17.05
Day’s range16.62 - 17.05
Volume261,635
Average volume (3 months)368,770
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)+5.13%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.45%
P/E ratioNM
Price/Sales3.67
Price/Book5.62

Competitors

 Today’s
change
Today’s
% change
BRLIBio-Reference Labora...-0.10-0.28%
SGMOSangamo BioSciences ...-0.32-1.84%
KERXKeryx Biopharmaceuti...+0.63+5.08%
DBVTDBV Technologies SA-0.43-1.97%
Data as of 4:00pm ET, 03/03/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$301.5M
Annual profit (last year)-$23.9M
Net profit margin-7.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Jeffrey H. Burbank
Senior Vice President-
Manufacturing Operations
Thomas F. Shea
Corporate headquarters
Lawrence, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account